Public signalCompany raiseAuto-indexed · Unverified
Araceli Biosciences Inc. raised $12.2M
Araceli Biosciences Inc.· TIGARD, US· Other Technology· Filed Dec 9, 2025
Araceli Biosciences Inc. reported raising capital. Based in TIGARD, OREGON, US. First sale reported 2024-12-31. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$12.2M
Confidence90%
Raised
$12.2M
Investors
28
Incorporated
2022
Jurisdiction
OREGON
On the record
- Location
- TIGARD, US
- Sector
- Other Technology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $12.2M
- Target amount
- $14.1M
- Filing date
- Dec 9, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- OREGON
- Year incorporated
- 2022
- Industry group
- Other Technology
- Number of investors
- 28
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $14.1M
- Amendment
- Yes
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Sources & provenance
“Operating company sold 12,236,994 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Dec 9, 2025. Details beyond the filing have not been verified.
Tags
AmendmentUSCompanyOther Technology$10M – $100MCompany Raise
Are you associated with Araceli Biosciences Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record